corona: corona vaccine / vaccine update / disease

Corona Vaccination in Ethiopia 

corona: corona vaccine / vaccine update / diseaseIn Ethiopia until yesterday, February 29, 2013. According to the data, 167,133 people were infected with the CVD virus. According to the Ministry of Health, 2,442 people died as a result of the virus. According to the Ministry of Health, the spread of the virus is on the rise. 

In Ethiopia until yesterday, February 29, 2013. According to the data, 167,133 people were infected with the CVD virus. According to the Ministry of Health, 2,442 people died as a result of the virus. According to the Ministry of Health, the spread of the virus is on the rise. 
Efforts to obtain a vaccine for this pandemic have yielded several proven vaccines from various organizations. The World Health Organization (WHO) has been working to make the vaccine available, especially to poor countries. It is still being distributed to various countries.
Ethiopia received 2.2 million doses of Astra Zenica vaccine from Covax, a global consumer and distributor of the Covad 19 vaccine, on Sunday. The first round of immunization will soon begin in all regions, especially for those in need, such as health professionals, the elderly and those with multiple sclerosis, and others who are forced to prioritize their work habits. 

The spread of the epidemic in Ethiopia is widely reported in Addis Ababa. The Ministry of Health, in particular Deutsche Welle, told Deutsche Welle that the distribution of the vaccine has been extended to all regions of the country. By the end of 2021, Ethiopia has plans to vaccinate 20% of its citizens with the same Covax vaccine. This means that given the size of the population, very few get this vaccine. While the vaccine is now promising, especially for health professionals and those suffering from chronic illness, it has already raised concerns about further neglect. It is also important to note that the precautionary measures taken in the past following the outbreak of the epidemic should not be used as a precautionary measure against vaccination. According to the Ministry of Health, 995 people were infected with the virus yesterday and 13 died of the disease.

A covide-19 vaccine to enter Ethiopia tomorrow

The first round of vaccine against CV-19 will enter Ethiopia tomorrow, June 28, 2013, according to the Ministry of Health.

The vaccine was obtained from the international consortium Covax and is estimated at 2.2 million doses, according to the Ministry of Health and the Ethiopian Institute of Public Health.

Preparations are underway to identify other sections of the community, including priority health workers.

Earlier, Health Minister Dr Leah Tadesse said the primary priority for the vaccine was to identify vulnerable groups.

According to him, health professionals, social health workers, and public transport providers will be given priority, and the task force set up at the national level will ensure better vaccination and control.

  • Ethiopia to immunize up to 9 million cholera vaccine in next two months.
  • Vaccination against Ethiopia and other countries began to spread.

In connection with this, a discussion was held yesterday, February 26, 2013, regarding the general preparations being made for the importation and distribution of the vaccine.

According to information obtained from the Ethiopian Institute of Public Health, a detailed review of the planned activities and preparations for the supply and distribution of the CVD-19 vaccine has been carried out.

Also, discussions were held on the quality of the vaccine, the work being carried out by the regulatory body, the specific parties to be vaccinated, and the efforts made to raise public awareness.

The Minister of Health, Dr Leah Tadesse, also gave guidance on issues to be addressed in the country regarding the Covide-19 vaccine.

Senior officials of the Ministry of Health, officials from the Ethiopian Institute of Public Health, the Ethiopian Food and Drug Control Authority, the Ethiopian Pharmaceutical Agency and various development partners participated in the forum.

What is Coax?

Since the introduction of the coronavirus vaccine, some of the richest countries in the world have been vaccinating their citizens.

Coax, developed by Dr Tedros' Office, is committed to ensuring that poor countries do not have to wait too long to receive the vaccine.

COVAX is an initiative launched by the World Health Organization and other international health organizations to provide vaccines to low- and middle-income countries.

All African countries have adopted this initiative.

Under this framework, rich nations provide financial assistance to less powerful nations.

In just one year, it is estimated that two billion vaccines will be distributed in 190 countries.

In particular, 92 poorer countries are expected to receive the vaccine on an equal footing with 98 other countries.

Many African countries, including Ethiopia, are beneficiaries of this program.

This means that through this initiative, Africa will receive 220 million vaccines.

However, few countries, such as Senegal, have been vaccinated.

The program has so far raised $ 6 billion for vaccines. Still, an additional $ 2 billion is said to be needed.

Despite criticism that the program is slow, the World Health Organization (WHO) and UNICEF say that this is the first round of vaccinations in Ghana.

By the end of 2021, Covax plans to purchase 2 billion CVD-19 vaccines.

Africa has received 270 million doses of the CV-19 vaccine from the African Union.

South African President Cyril Ramaphosa has promised that the vaccine will be used this year.

The vaccine is in addition to the previously promised 600 million doses but is still not enough to cover the entire continent.

There are fears that the world's poorest nations may have to wait longer to be vaccinated than rich countries.

Health Minister Dr Leah said Ethiopia and similar countries are working with the Kovac Vaccination Institute to vaccinate 20 per cent of the population by the end of 2021.

Although the number of people infected and dying in Africa is relatively low, the number of people living with the virus is rising again.

In Ethiopia, the number of people infected with the virus has been steadily increasing since the outbreak, with 164,773 people infected so far. Of these, 137,431 recovered and 2,404 died.

UEE developed a vaccine called corticosteroids

corona: corona vaccine / vaccine update / disease

Process and progression of cholera vaccines

Over the past year since the outbreak of cholera, researchers have been conducting extensive scientific research to find drugs and vaccines to prevent and control the epidemic. Some have been reported to be effective.

The covide-19 outbreak is a pandemic and a global health threat; It has been almost a year since the World Health Organization (WHO) announced the outbreak on January 30. Several research groups around the world have been conducting scientific studies to develop a vaccine to prevent this epidemic. So far, only a handful of research teams have been able to extend their experimental vaccines to the third round of clinical trials. 

The European Medicines Agency recently announced that it has approved the corticosteroid vaccine "AstraZeneca". The agency said it was safe and effective to prevent CV-19. The technology used to make the vaccine is different, said Emmer Cook, the agency's director.

he said. We are based on reliable information on the vaccine protection against Covide-19. The first two certified vaccines were developed using the "Message RNA" method, while Astrozenika was developed with another technology called Dino Virus. This means that the vaccine is designed to contain a certain amount of cova-19 coronavirus protein from another common bacterium, the Dino family.

However, the EU is sceptical that the vaccine will be effective for the elderly. He said he could not recommend the vaccine to people 65 years of age and older because he did not have enough information. Experts from the European Medicines Agency said the vaccine could also be effective for people over the age of 55. Following this expert advice, the European Commission has given the final confirmation that the vaccine will be used by the 27 member states. The vaccine can be stored in a regular refrigerator, so it is easy to transport, according to Emer Cook.  

On the other hand, the promising vaccine, developed by the US company Novavax, is expected to be recognized. In Australia and other countries, it has been reported that they have received the CVD-19 vaccine. 

Over the past year, researchers have been doing a lot of scientific research to find drugs and vaccines to prevent and control the epidemic, including these new vaccines. According to the World Health Organization (WHO), there were at least 246 studies during the outbreak of cholera. Of these, more than 100 research teams are trying to develop a safe and effective CV-19 vaccine. More than 50 have begun clinical trials. 

However, only a few of these studies have been confirmed, because it takes an average of 10 to 15 years for scientific research to find a vaccine that is not easy.

"Both words show how well a vaccine can protect people from disease," he said. Success is a testament to the effectiveness of the vaccine in a controlled environment during clinical trials. But the effectiveness of the vaccine is how it protects people in the real world. ”

Still, many research teams are in the process of reaching the vaccine as soon as possible. Most studies, however, are still prerequisite: That is, they are undergoing clinical trials with animals. If these studies are successful, they could be turned into a clinical trial that could be tested by humans.

To ensure the effectiveness and safety of a vaccine, it is necessary to pass three clinical trials. Organizations are vaccinated so far.

Researchers also begin to monitor changes in people who have been vaccinated in this way. Experts say there are no side effects other than this.

In general, these types of side effects do not last long. They do not cause any other side effects.

Researchers are using 12 different methods to obtain the CV-19 vaccine: Evidence suggests that most studies have followed the method of using the protein subunit instead of the pathogen. 19 Vaccines At the end of January 2021, five research groups tested more than 300,000 volunteers around the world.

On the other hand, rich countries are now buying mass vaccines to prevent the spread of disease, which has killed hundreds of millions of people and killed more than 2.5 million people. However, many questions remain about the safety, effectiveness and inaccessibility of the vaccine to Africans. South African President Cyril Ramaphosa is also concerned.

The distribution of the first CVD-19 vaccine is limited and requires sequencing?

However, there is a supply limit when the vaccine is first available. Vaccination is first given to certain people who are at high risk for CVD-19 or other serious health problems such as CVD-19 infection, such as health care workers, nursing homes or assisted living facilities, and other critical care workers.

The Washington State Department of Health (DOH) has provided the vaccine to several hospitals, pharmacies, and health systems registered to receive the vaccine. DOH and Seattle and King County Community Health are working with several partners to increase access to immunization sites and immunizations.

Who can vaccinate now?

As of March 31, 2021, the Washington State Department of Health has begun distributing the Round 1b4 vaccine.

The vaccine is available for the following groups, regardless of insurance, citizenship or immigration status. You do not pay for the vaccine or receive a receipt. The cost of the vaccine will be covered by Medicare, Medicaid and most private insurance companies, and the cost of the vaccine will be covered by uninsured people.

New Qualifications (as of 3/31/21):

  • An individual between the ages of 60(sixty) and 64(sixty-four)

  • Eligible for Level 1b3: 16 or older and have more than one medical condition or basic health problem on the CDC Health List(Website in English)

  • Eligible for Level 1b4 :
    • Individuals (residents, workers, volunteers) at some of the most vulnerable places:
      • It includes group housing for people with disabilities, severe mental illness, mental development and cognitive impairment, and accommodation for people with disabilities, as well as rehabilitation facilities not included in Level 1 drug addicts.
      • Prisons, prisons, short-term detention centres, and similar institutions
      • Institutions that provide services to homeless individuals (such as temporary housing)
      • Domestic Violence for Refugees
    • Employees of the following industries who are at high risk of aggravated seizures:
      • Restaurant and catering service
      • Manufacturing
      • Construction

      Note Collaborating means working in a closed building where it is not possible to work remotely. Employees who work in such facilities but can work remotely, work remotely, or work off-site are not included in this category.

Vaccination is also open to the following individuals:

  • Applicable to Round 1a (website only available in English): Anyone with a high risk of COVID-19 in health facilities due to their work, long-term care centre staff and residents, and health and care assistants.

  • Appropriate for round 1b1
    • 65 years and older
    • If two or more generations are living in the household (age 50 and older) (ie, an older person and his or her grandchild), and he/she meets the following requirements:
      • If you cannot live alone and have a relative or helper (paid or unpaid) or working outside the home
      • Living with or caring for a minor child, such as grandparents and great-grandchildren.
    • Prices up to 12th-grade teachers and staff
    • Childcare staff include:
      • Licensed family child care providers and family members living in their home.
      • Unauthorized families, friends, and neighbourhood providers receive child care subsidies for work relationships. These in-house providers can serve up to 6 children.
      • ECEAP, Washington State-funded Press School School Providers. This is similar to the Federal Hestart program.
      • Unauthorized school-age and youth development providers who have been caring for school children since the outbreak began and schools have been relocated to online or hybrid teaching.

  • Appropriate for round 1b2
    • Meet the high-risk workers in the following industries that require a large number of people.
      • Farm
      • Fishing boat crew
      • Food preparation
      • Grocery Store and Food Bank
      • Detention Centers (Prisons and Detention Centers)
      • Courts
      • Quick Assistants are not included in the first level (excluding administrators and remote-controlled)
      • Kindergarten Lite Child Care Program Staff Workers Young Growing Day Day Camp (Day Camp) and not included in Level 1b1

The cost of the vaccine?

  • The CVD vaccine is covered by Medicare, Medicaid and several private insurance policiesThe cost of the vaccine will also be covered by uninsured people. There may be a cost-sharing fee or an office visit depending on your insurance plan or the doctor you see to get vaccinated.
  • Public immunizations are being planned by public health clinics at low cost or free immunizations.

It is important to follow all kind of precautions?

  • A safe and effective CV-19 vaccine is a major breakthrough. Vaccination alone does not stop the epidemic right now.
  • Stopping the epidemic even after the vaccine is given requires everyone to follow all current guidelines to protect themselves and others, even if they have been vaccinated. These include wearing a mask, staying away from at least 6 people, restricting outdoor activities and crowding, regular hand washing, following the CDC Travel Guidelines, and following CV-19 after exposure to each person.

Coronavirus: Russia has started vaccinating Moscow residents against Covid-19

Russia has launched a program to vaccinate the most at-risk citizens in Moscow.

corona: corona vaccine / vaccine update / disease

Russia was the first country in the world to issue a Sputnik V ticker license for local use last August without disclosing any information. 
Now it has started to be used.

Russia was the first country in the world to issue a ticker license for local use last August without disclosing any information.

So far, 23,72,012 coronavirus patients have been identified in Russia, of whom 41,630 have died.

Moscow has become the epicentre of the epidemic in Russia, where thousands of people are infected with the coronavirus every day.

The BBC's Sarah Rainsford in Moscow says the Russian government has rejected the lockdown proposal and insisted on finding a more effective vaccine.

However, despite the approval, the official implementation of the vaccine has not yet begun among the people.